JRSIS HEALTH CARE Corp (JRSS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 6M 12M 18M Q1 '14: 1.5M Q2 '14: 1.5M Q3 '14: 1.4M Q4 '14: 1.5M Q1 '15: 2.4M Q2 '15: 2.7M Q3 '15: 2.9M Q4 '15: 3.8M Q1 '16: 4.4M Q2 '16: 4.3M Q3 '16: 4.3M Q4 '16: 5.2M Q1 '17: 5.5M Q2 '17: 5.4M Q3 '17: 5.7M Q4 '17: 7.6M Q1 '18: 6.8M Q2 '18: 7M Q3 '18: 6.8M Q4 '18: 7.8M Q1 '19: 7.6M Q2 '19: 7.6M Q3 '19: 7.8M Q4 '19: 8.6M Q1 '20: 6M Q2 '20: 7M Q3 '20: 10M Q4 '20: 12.7M Q1 '21: 7.3M Q2 '21: 11.7M Q3 '21: 12.2M Q4 '21: 13.2M Q1 '22: 15.6M Q1 '23: 477K Q2 '23: 337.4K Q3 '23: 497.4K Q4 '23: 2.2M Q1 '24: 500.4K Q2 '24: 597.4K Q3 '24: 222.9K Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q2 '23 Q3 '24

Gross Profit Quarterly

0 70K 140K 210K Q1 '23: 151.4K Q2 '23: 39.6K Q3 '23: 120.1K Q4 '23: 171.9K Q1 '24: 57.2K Q2 '24: 186.1K Q3 '24: 26.9K Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24

Operating Income Quarterly

-1M 0 1M 2M 3M Q1 '14: 258.7K Q2 '14: 298.1K Q3 '14: 238.9K Q4 '14: 122.3K Q1 '15: 459.5K Q2 '15: 530.1K Q3 '15: 600.4K Q4 '15: 1M Q1 '16: 1.4M Q2 '16: 1.1M Q3 '16: 1.2M Q4 '16: 1.3M Q1 '17: 1.6M Q2 '17: 1.3M Q3 '17: 1.5M Q4 '17: 2.2M Q1 '18: 2.3M Q2 '18: 2.1M Q3 '18: 1.6M Q4 '18: 332.5K Q1 '19: 1.2M Q2 '19: 1.3M Q3 '19: 1.1M Q4 '19: 1.1M Q1 '20: 376.5K Q2 '20: 653.7K Q3 '20: 1.9M Q4 '20: 2.7M Q1 '21: 706.3K Q2 '21: -1.5K Q3 '21: -7.5K Q1 '22: -22.3K Q2 '22: -127.3K Q3 '22: -132.5K Q4 '22: -402.7K Q1 '23: 77.5K Q2 '23: -127.3K Q3 '23: 51K Q4 '23: -189.8K Q1 '24: -160.9K Q2 '24: -118.7K Q3 '24: -206.2K Q2 '15 Q4 '16 Q2 '18 Q4 '19 Q2 '21 Q1 '23 Q3 '24

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '14: 168.4K Q2 '14: 204K Q3 '14: 163.4K Q4 '14: 75.7K Q1 '15: 324K Q2 '15: 362K Q3 '15: 396.8K Q4 '15: 707.9K Q1 '16: 940.3K Q2 '16: 794.8K Q3 '16: 813.1K Q4 '16: 923.8K Q1 '17: 1.1M Q2 '17: 913.3K Q3 '17: 1.1M Q4 '17: 1.6M Q1 '18: 1.4M Q2 '18: 1.4M Q3 '18: 1.1M Q1 '19: 668.6K Q2 '19: 654.7K Q3 '19: 475.3K Q1 '20: 314.9K Q2 '20: 403.1K Q3 '20: 1M Q4 '20: 2.6M Q1 '21: 495.9K Q2 '21: 1M Q3 '21: 541.5K Q4 '21: 1.1M Q1 '22: 2.6M Q2 '22: -36.2M Q3 '22: -132.5K Q1 '23: 45.4K Q2 '23: -106K Q3 '23: 33.7K Q4 '23: -54K Q1 '24: -145.4K Q2 '24: -102.4K Q3 '24: -188.1K Q1 '15 Q2 '16 Q3 '17 Q1 '19 Q3 '20 Q4 '21 Q2 '23 Q3 '24

Cost of Revenue Quarterly

0 700K 1.4M 2.1M Q1 '23: 325.6K Q2 '23: 297.8K Q3 '23: 377.3K Q4 '23: 2M Q1 '24: 443.2K Q2 '24: 411.3K Q3 '24: 196K Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '14: 304K Q2 '14: 789.2K Q3 '14: 147.8K Q4 '14: 813.2K Q1 '15: 337.2K Q2 '15: 226.1K Q3 '15: 864.5K Q4 '15: 1.1M Q1 '16: 1.4M Q2 '16: 2.1M Q3 '16: 491.7K Q4 '16: 1.1M Q1 '17: 216K Q2 '17: 1.7M Q3 '17: 2.3M Q4 '17: 4.2M Q1 '18: 2.1M Q2 '18: 640.3K Q3 '18: 4.5M Q4 '18: 2M Q1 '19: 3.3M Q2 '19: 3.2M Q3 '19: 2.4M Q4 '19: 3M Q1 '20: 1.5M Q2 '20: 1.7M Q3 '20: 4.3M Q4 '20: 3.1M Q1 '21: 267.1K Q2 '21: 3.4M Q3 '21: 3.8M Q4 '21: 854.5K Q1 '22: 4.6M Q2 '22: -1.6M Q3 '22: -32.7K Q4 '22: -4.8M Q1 '23: -16.5K Q2 '23: 527.5K Q3 '23: -90K Q4 '23: 95.8K Q1 '24: -204.9K Q2 '24: -268.9K Q3 '24: -352.3K Q1 '14 Q3 '15 Q1 '17 Q3 '18 Q1 '20 Q3 '21 Q1 '23 Q3 '24

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '14: 43.5K Q2 '14: -163.1K Q3 '14: -537.8K Q4 '14: -881.8K Q1 '15: -478.3K Q2 '15: -1.4M Q3 '15: -480.2K Q4 '15: -296K Q1 '16: 1.3M Q2 '16: 412.4K Q3 '16: -1.1M Q4 '16: 943.4K Q1 '17: -157.2K Q2 '17: 1.1M Q3 '17: 2M Q4 '17: 2.2M Q1 '18: 1.4M Q2 '18: -766.5K Q3 '18: -454.6K Q1 '19: 1.8M Q2 '19: 2.6M Q3 '19: 1.6M Q4 '19: 1.2M Q1 '20: 1.2M Q2 '20: 768.8K Q3 '20: 825.8K Q4 '20: -457.1K Q1 '21: 139.2K Q2 '21: 2.9M Q3 '21: 1.4M Q1 '22: 3.5M Q3 '22: -34.6K Q4 '22: -4.8M Q4 '23: 94.5K Q3 '24: -419.9K Q1 '15 Q2 '16 Q3 '17 Q1 '19 Q2 '20 Q3 '21 Q3 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q1 '14: 13.2M Q1 '15: 13.7M Q2 '18: 15M Q3 '18: 15M Q1 '19: 15M Q2 '19: 16.1M Q3 '19: 18.1M Q1 '20: 18M Q2 '20: 18M Q3 '20: 18.1M Q1 '21: 18.5M Q2 '21: 18.5M Q3 '21: 18.8M Q1 '22: 18.8M Q2 '22: 4.4M Q3 '22: 5.8M Q1 '23: 76.8M Q2 '23: 76.8M Q3 '23: 76.8M Q1 '24: 84.3M Q2 '24: 84.6M Q3 '24: 84.6M Q1 '14 Q3 '18 Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q4 '14: 0.05 Q1 '15: 0.06 Q2 '15: 0.07 Q3 '15: 0.08 Q4 '15: 0.13 Q1 '16: 0.17 Q2 '16: 0.20 Q3 '16: 0.23 Q4 '16: 0.25 Q1 '17: 0.26 Q2 '17: 0.27 Q3 '17: 0.29 Q4 '17: 0.32 Q1 '18: 0.34 Q2 '18: 0.37 Q3 '18: 0.37 Q4 '20: 0.15 Q1 '21: 0.16 Q2 '21: 0.19 Q3 '21: 0.18 Q4 '21: 0.16 Q1 '22: 0.28 Q2 '22: -8.02 Q3 '22: -8.07 Q4 '23: -0.00 Q1 '24: -0.00 Q2 '24: -0.00 Q3 '24: -0.01 Q3 '15 Q3 '16 Q3 '17 Q3 '18 Q3 '21 Q3 '22 Q3 '24

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.